Skip to main content
. 2022 Aug 31;609(7927):569–574. doi: 10.1038/s41586-022-05137-7

Fig. 2. Combinatorial strategy for specific iWAT-DRG manipulation.

Fig. 2

a,b, Comparison of ROOT and AAV9 for retrograde labelling in the iWAT. a, Representative whole-mount images of DRGs (T13) and SChGs (T12) labelled by ROOT-mScarlet or AAV9-mScarlet and a sequential CTB-647 injection from iWAT. Some of the AAV and CTB double-positive cells are highlighted by white arrows. CTB labels 26.42 ± 6.49% of ROOT-labelled neurons, and 9.95 ± 0.92% of AAV9-labelled neurons in T13/L1 DRGs. Data are mean ± s.e.m. n = 4 mice per group. b, Representative images of livers from animals with ROOT-mScarlet or AAV9-mScarlet injected into the iWAT. cf, Combinatorial viral strategy for Cre-dependent ablation of iWAT DRGs. c, Schematic of the combinatorial viral strategy for unilateral sensory ablation. Each mouse has AAV-mCherry-flex-DTA injected into the bilateral T13/L1 DRGs, and ROOT-YFP or ROOT-Cre injected into the iWAT unilaterally. Three weeks after surgery, CTB-647 was injected into the iWAT bilaterally. d, Representative whole-mount images of contralateral (Cre) and ipsilateral (Cre+) DRGs (T13) and SChGs (T12). e,f, Quantification of CTB+ cell numbers (e) and normalized cell numbers (f) in T13 and L1 DRGs labelled from iWAT. n = 10 mice. Statistical analysis was performed using two-tailed paired t-tests. P values are shown at the top. For a,b and d, scale bars, 200 μm.

Source data